[Vaccination against bluetongue: safety and immune response in the field].
Bluetongue, caused by the bluetongue virus serotype 8 has rapidly spread through Europe since 2006. The first cases in Switzerland were detected in October 2007. The European Union and Switzerland launched a vaccination campaign in June 2008. This study aims to demonstrate the safety and the immune response of the three vaccines used in Switzerland under practical conditions in the field. The trial was carried out in cattle, sheep and goats. Based on the results of this study recommendations for the 2009 campaign are presented.
Bruckner
L
L
Institut für Viruskrankheiten und Immunprophylaxe (IVI), Mittelhäusern. lukas.bruckner@ivi.admin.ch
Fricker
R
R
Hug
M
M
Hotz
R
R
Muntwyler
J
J
Iten
C
C
Griot
C
C
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D001819:Bluetongue / Q000517:prevention & control*; D001820:Bluetongue virus / Q000276:immunology*; D002417:Cattle; D002418:Cattle Diseases / Q000517:prevention & control*; D005260:Female; D015511:Goat Diseases / Q000517:prevention & control*; D006041:Goats; D007018:Hypopituitarism; D008297:Male; D013557:Switzerland / Q000453:epidemiology; D016896:Treatment Outcome; D014611:Vaccination / Q000662:veterinary*; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology
D000914:Antibodies, Viral; D014765:Viral Vaccines